RTLS Technology Study

January 12, 2022 updated by: The Royal Wolverhampton Hospitals NHS Trust

A Retrospective, Observational Analysis Using Real Time Location Systems (RTLS) Technology to Explore the Effects of Clinical Staffing on Hospital Productivity and Patient Health Outcomes

This study will examine the productivity of the hospital workforce utilizing a unique dataset that is stored at the Royal Wolverhampton Trust (RWT). The data is recorded by a Real Time Location System (RTLS) that tracks the second-by-second physical location of patients, staff, and medical equipment. Using this data, the plan is to measure the amount of time that clinical staff spend with patients and with other clinical staff, and then explore how these measures of contact time influence patient health outcomes. The data will also be used to measure the location and movement of patients during their hospital stay, and test the impact of moving patients between wards on their health outcomes. In light of the recent COVID-19 outbreak, impact of COVID19 on patient contact time, patient outcomes and professional working practices will also be examined.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United Kingdom
    • West Midlands
      • Wolverhampton, West Midlands, United Kingdom, WV10 0QP
        • The Royal Wolverhampton NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All admitted inpatients between 1 April 2016 and 31 March 2019, and all staff members with RTLS badges, at The Royal Wolverhampton NHS Trust (RWT), Wolverhampton.

Description

Inclusion Criteria:

  • Patients admitted to inpatient departments at RWT and are present at RWT during the period of 1 April 2016 to 31 March 2019 inclusive.

Exclusion Criteria:

  • Patients admitted to outpatient wards at RWT;
  • Patients that were not admitted at or discharged from RWT between 1 April 2016 to 31 March 2019 inclusive.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Admitted inpatients
no intervention
Other: RTLS data
data extraction from RTLS
Staff with RTLS badges
no intervention
Other: RTLS data
data extraction from RTLS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of in-hospital deaths (RWT specific)
Time Frame: 30 days
in-hospital mortality figures
30 days
Number of readmissions (RWT specific)
Time Frame: 30 days
readmission figures
30 days
Length of stay
Time Frame: 3 years
total amount of time in hospital
3 years
Nurse sensitive indicators
Time Frame: 3 years
Number of Falls, medication errors, pressure ulcers and Urinary Tract Infections
3 years
Number of Adverse incidents affecting patient care
Time Frame: 3 years
Number and description of Adverse incidents affecting patient care as recorded by the Datix information system (e.g. falls, medication errors)
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The Royal Wolverhampton Hospitals NHS Trust

Collaborators

Cornell University
La Trobe University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 6, 2020

Primary Completion (Actual)

November 15, 2021

Study Completion (Actual)

November 15, 2021

Study Registration Dates

First Submitted

October 1, 2019

First Submitted That Met QC Criteria

October 1, 2019

First Posted (Actual)

October 3, 2019

Study Record Updates

Last Update Posted (Actual)

January 28, 2022

Last Update Submitted That Met QC Criteria

January 12, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2019SUR107

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No participant data is planned to be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Staff

Clinical Trials on RTLS data

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe